Latest SATTER MANAGEMENT CO., L.P. Stock Portfolio

$56.80Million | No. of Holdings #5

SATTER MANAGEMENT CO., L.P. Performance

2024 Q4-1.57%

YTD-1.38%

2023-24.93%

About SATTER MANAGEMENT CO., L.P. and 13F Hedge Fund Stock Holdings

On 2025-02-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Alerce Investment Management, L.P. reported an equity portfolio of $56.8 Millions as of 31 Dec, 2024. <br><br> The top stock holdings of Alerce Investment Management, L.P. are ANNX, AKBA, VRNA. The fund has invested 66.9% of it's portfolio in ANNEXON INC and 19.2% of portfolio in AKEBIA THERAPEUTICS INC. <br><br> They significantly reduced their stock positions in VERONA PHARMA PLC (VRNA).

SATTER MANAGEMENT CO., L.P. Equity Portfolio Value

Last Reported on: 14 Feb, 2025

$56.80Million

as of Feb 14, 2025

SATTER MANAGEMENT CO., L.P. Annual Return Estimates Vs S&P 500

Our best estimate is that Alerce Investment Management, L.P. made a return of -1.57% in the last quarter. In trailing 12 months, it's portfolio return was -1.38%.

Performance
S&P 500

New Buys

No new stocks were added by SATTER MANAGEMENT CO., L.P.

Additions

No additions were made to existing positions by SATTER MANAGEMENT CO., L.P.

Reductions

Ticker	% Reduced
verona pharma plc	-57.26

SATTER MANAGEMENT CO., L.P. reduced stake in above stock

Sold off

None of the stocks were completely sold off by SATTER MANAGEMENT CO., L.P.

Sector Distribution

Alerce Investment Management, L.P. has about 100% of it's holdings in Healthcare sector.

Healthcare

Sector	%
Healthcare	100

Market Cap. Distribution

Alerce Investment Management, L.P. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

SMALL-CAP
MICRO-CAP
MID-CAP

Category	%
SMALL-CAP	66.9
MICRO-CAP	25.9
MID-CAP	7.2

Stocks belong to which Index?

About 73.6% of the stocks held by Alerce Investment Management, L.P. either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others

Index	%
RUSSELL 2000	73.6
Others	26.4

Top 5 Winners (%)		%
AADI	aadi bioscience inc	53.1 %
VRNA	verona pharma plc	45.7 %
AKBA	akebia therapeutics inc	43.9 %

Top 5 Winners ($)		$
AKBA	akebia therapeutics inc	3.3 M
VRNA	verona pharma plc	2.7 M
AADI	aadi bioscience inc	0.0 M

Top 5 Losers (%)		%
AMWL	american well corp	-23.5 %
ANNX	annexon inc	-13.3 %

Top 5 Losers ($)		$
ANNX	annexon inc	-5.9 M
AMWL	american well corp	-1.2 M

SATTER MANAGEMENT CO., L.P. Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SATTER MANAGEMENT CO., L.P.

Alerce Investment Management, L.P. has 5 stocks in it's portfolio. ANNX proved to be the most loss making stock for the portfolio. AKBA was the most profitable stock for Alerce Investment Management, L.P. last quarter.

$56.80MTotal Value

5.00Positions

14 Feb, 2025Last Reported

Current holdings of Current Stock Holdings of SATTER MANAGEMENT CO., L.P., last reported on 14 Feb, 2025. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
AADI Aadi Bioscience Inc Aadi Bioscience IncAADI SATTER MANAGEMENT CO., L.P.'s holding in Aadi Bioscience Inc over time	0%	659	$2.1K 0%	unchanged 0 percentunchanged

AKBA Akebia Therapeutics Inc Akebia Therapeutics IncAKBA SATTER MANAGEMENT CO., L.P.'s holding in Akebia Therapeutics Inc over time	19.23%	5,747,910	$10.92M 19.23%	unchanged 0 percentunchanged

AMWL American Well Corp American Well CorpAMWL SATTER MANAGEMENT CO., L.P.'s holding in American Well Corp over time	6.69%	523,785	$3.80M 6.69%	unchanged 0 percentunchanged

ANNX Annexon Inc Annexon IncANNX SATTER MANAGEMENT CO., L.P.'s holding in Annexon Inc over time	66.89%	7,406,020	$37.99M 66.89%	unchanged 0 percentunchanged

VRNA Verona Pharma Plc Verona Pharma Plc VRNA SATTER MANAGEMENT CO., L.P.'s holding in Verona Pharma Plc over time	7.2%	88,000	$4.09M 7.2%	decreased 57.26 percentreduced